Amitriptyline versus Carbamazepine in the treatment of painful diabetic neuropathy
Not Applicable
- Conditions
- painful diabetic neuropathy.Diabetic polyneuropathy
- Registration Number
- IRCT138905024435N1
- Lead Sponsor
- Ahvaz Jundishapour University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age 18-65 y/o, confirmed diabetic neuropathy with EMG/NCV
Exclusion criteria: pregnancy, breast feeding, recent MI, allergy to drugs, past hx. of seizure, mood disorder, diabetic cystopathy or gastroparesis, renal or hepatic failure, hypothyroidism.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Painful neuropathy. Timepoint: 6 weeks. Method of measurement: brief pain inventory (quantitative scale).
- Secondary Outcome Measures
Name Time Method Drugs complications. Timepoint: 6 weeks. Method of measurement: by history and assessment.